Tufts R&D Cost Estimate Puts Cash Outlay At $403 Mil. Per NCE
The cash outlay required to complete development of a new chemical entity has increased to an average of more than $400 mil., the Tufts Center for the Study of Drug Development says
The cash outlay required to complete development of a new chemical entity has increased to an average of more than $400 mil., the Tufts Center for the Study of Drug Development says